Metabolomics Offers New Insights into Chronic Fatigue Syndrome
Using metabolomic and microbiomic data, Mailman researchers are trying to create a test to identify chronic fatigue syndrome.
About author
Related Articles
-
-
-
Inflammation may indicate increased risk of dementia in later life
February 14, 2019 -
Categories
Recent Posts
- Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
- Innovative compound offers a new therapeutic approach to treat multiple sclerosis
- $1.5 million grant to develop opioid treatment program for jail detainees
- FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
- Most Hip, Knee Replacements Last Decades, Study Finds
- Wellness problems prevalent among ob-gyn residents
- In the Spotlight: “The world is your oyster in geriatrics”
- Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
- Analysis of cervical precancer shows decline in two strains of HPV
- Sugary stent eases suturing of blood vessels
- From surgery to psychiatry: A medical student reevaluates his motivations
- Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
- New pacemakers powered by heartbeats could reduce need for surgery
- The United States records highest drug overdose death rates
- Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
- Vitamin D supplementation less effective in the presence of obesity, shows study
- Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
- An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
- Failure to take statins leads to higher mortality rates | News Center
- New study explains why some patients report phantom sensations after limb amputation